These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54. Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex. Venkataraman G; Raman R; Sasisekharan V; Sasisekharan R Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3658-63. PubMed ID: 10097093 [TBL] [Abstract][Full Text] [Related]
55. VEGF-A/VEGFR-2 and FGF-2/FGFR-1 but not PDGF-BB/PDGFR-β play important roles in promoting immature and inflammatory intraplaque angiogenesis. Mao Y; Liu X; Song Y; Zhai C; Zhang L PLoS One; 2018; 13(8):e0201395. PubMed ID: 30125282 [TBL] [Abstract][Full Text] [Related]
56. Direct FGF receptor 1 activation through an anti-idiotypic strategy mimicks the biological activity of FGF-2 and inhibits the progression of the bladder carcinoma derived from NBT-II cells. Malavaud B; Pedron S; Sordello S; Mazerolles C; Billottet C; Thiery JP; Jouanneau J; Plouët J Oncogene; 2004 Sep; 23(40):6769-78. PubMed ID: 15273729 [TBL] [Abstract][Full Text] [Related]
57. In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase. Panek RL; Lu GH; Dahring TK; Batley BL; Connolly C; Hamby JM; Brown KJ J Pharmacol Exp Ther; 1998 Jul; 286(1):569-77. PubMed ID: 9655904 [TBL] [Abstract][Full Text] [Related]